Carmell Therapeutics (CTCX)
Search documents
Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024
Newsfilter· 2024-02-26 13:30
PITTSBURGH, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell" or the "Company"), today announced that they have completed product development of their Gold Limited Edition Exclusive (G.L.E.E.) product for commercial launch in March 2024. Additionally, the Company is in advanced stages of development and testing of 9 other skincare products anticipated to launch over Spring and Summer 2024. The Carmell skincare product por ...
Carmell Therapeutics (CTCX) - 2023 Q3 - Quarterly Report
2023-11-14 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-40228 CARMELL CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 86-1645738 ( State or other jurisdiction of incorporation or organiza ...
Carmell Therapeutics (CTCX) - 2023 Q2 - Quarterly Report
2023-08-13 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Carmell Corporation (Exact name of registrant as specified in its charter) Delaware 001-40228 86-1645738 (State or other jurisdiction of incorporation) (Commission File Num ...
Carmell Therapeutics (CTCX) - 2023 Q1 - Quarterly Report
2023-05-14 16:00
Alpha Healthcare Acquisition Corp. III (Exact name of registrant as specified in its charter) Page No. PART I. FINANCIAL INFORMATION Item 1. Condensed Consolidated Financial Statements 1 Condensed Consolidated Balance Sheets as of March 31, 2023 (Unaudited) and December 31, 2022 1 Condensed Consolidated Statements of Operations (Unaudited) 2 Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited) 3 Condensed Consolidated Statements of Cash Flows (Unaudited) 4 Notes to Cond ...
Carmell Therapeutics (CTCX) - 2022 Q4 - Annual Report
2023-03-16 16:00
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ☐ No ☒ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. Indicate by check mark whether the re ...
Carmell Therapeutics (CTCX) - 2022 Q3 - Quarterly Report
2022-11-09 16:00
Table of Contents Title of each classTrading Symbol(s)Name of each exchange on which registered Units, each consisting of one share of Class A Common Stock and one-fourth of one Redeemable Warrant ALPAU The Nasdaq Stock Market LLC Class A Common Stock, par value $0.0001 per share ALPA The Nasdaq Stock Market LLC Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 ALPAW The Nasdaq Stock Market LLC UNITED STATES SECURITIES AND EXCHANGE COMMI ...
Carmell Therapeutics (CTCX) - 2022 Q2 - Quarterly Report
2022-08-09 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each classTrading Symbol(s)Name of each exchange on which registered Units, each consisting of one share of Class A Common Stock and one-fourth of one Redeemable Warrant ALPAU The Nasdaq Stock Market LLC Class A Common Stock, par value $0.0001 per share ALPA The Nasdaq Stock Market LLC Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 ALPAW The Nasdaq Stock ...
Carmell Therapeutics (CTCX) - 2022 Q1 - Quarterly Report
2022-05-19 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Alpha Healthcare Acquisition Corp. III (Exact name of registrant as specified in its charter) Delaware 001 - 40228 86-1645738 (State or other jurisdiction of incorporation ...
Carmell Therapeutics (CTCX) - 2021 Q4 - Annual Report
2022-04-14 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001-40228 Alpha Healthcare Acquisition Corp. III (Exact name of Registrant as specified in its charter) Delaware 85-16 ...
Carmell Therapeutics (CTCX) - 2021 Q3 - Quarterly Report
2021-11-21 16:00
Table of Contents Trading Name of each exchange Title of each class Symbol(s) on which registered Units, each consisting of one share of Class A Common Stock and one-fourth of one Redeemable Warrant ALPAU The Nasdaq Stock Market LLC Class A Common Stock, par value $0.0001 per share ALPA The Nasdaq Stock Market LLC Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 ALPAW The Nasdaq Stock Market LLC UNITED STATES SECURITIES AND EXCHANGE COM ...